Dolphin Group utilises Epicor ERP to help aid business growth
The US-based software company, Epicor Software Corporation, has announced that Dolphin Group has begun to utilise its global enterprise resource planning (ERP) solution, Epicor ERP.
Dolphin Group, a leading manufacturer of high performance industrial and automotive thermal products in the United Arab Emirates, has started to use Epicor ERP in its seven business units and 11 facilities in the UAE.
Through the venture, Epicor is enabling Dolphin Group’s employees to become more efficient and is allowing for faster and better critical business decisions by breaking down data siloes and easing visibility and transparency across departments.
- Volkswagen announces intention to develop 10mn EV vehicles by 2022
- Number of robots and machines in workplace set to double the jobs it will replace by 2025
- BMW set to agree additional deals with mining firms to reduce EV battery costs
- Read the latest issue of Manufacturing Global here!
Arshid Zab, IT manager at Dolphin Group, said: “Close to 90% of our product offering is built-to-order which means that our ability to deliver the highest quality product to our customers, on time, every time, hinges on having best-in-class manufacturing processes. As such, our number one priority was to find a vendor that offered an industry-specific solution with a strong track record of success in the region. This is what really sets Epicor apart from most other vendors.”
“With Epicor ERP serving as the backbone of our business, I am confident that we will be able to stay true to our core values of adaptability, continuous improvement, entrepreneurship and teamwork, and execute on our ambitious growth strategy.”
As a result of the operational improvements, Dolphin is expected to create new product lines, increase operations and grow its revenue streams.
IMF: Variants Can Still Hurt Manufacturing Recovery
After a year of on-and-off manufacturing in the US, UK, and the eurozone, demand for goods surged early last week. Factories set growth records in April and May, suppliers started to recover, and US crude hit its highest price point since pre-COVID. As vaccination efforts immunise much of the US and UK populations, manufacturers are now able to fully ramp up their supply chains. In fact, GDP growth could approach double-digits by 2022.
Now, the ISM productivity measure has surpassed the 50-point mark that separates industry expansion from contraction. Since U.S. president Biden passed his US$1.9tn stimulus package and the UK purchasing managers index (PMI) increased to 65.6, both sides of the Atlantic are facing a much-welcomed manufacturing recovery.
Lingering Concerns Over COVID
Even as Spain, France, Italy, and Germany race to catch up, and mining companies pushed the FTSE 100 index of list shares to a monthly high of 7,129, some say that UK and US markets still suffer from a lack of confidence in raw material supplies. Yes, the Dow Jones has made up its 19,173-point crash of March 2020, and MSCI’s global stock index is at an all-time high.
Yet manufacturers around the world realise that these wins will be short-lived until pandemic supply chain bottlenecks are solved. If we keep the status quo, consumers will pay the price. In April, inflation in Germany reached 2.4%, and across the EU’s 19 member countries, overall prices have increased at an unusual pace. Some ask: Is this true recovery?
IMF: Current Boom Could Falter
Even as Elon Musk tweeted about chip shortages forcing Tesla to raise its prices, UK mining demand skyrocketed; housing markets lifted; and the pound sterling gained value. The International Monetary Fund (IMF), however, cautioned that manufacturing recovery won’t last long if COVID mutates into forms our vaccinations can’t touch. Kristalina Georgieva, Washington’s IMF director, noted that fewer than 1% of African citizens have been vaccinated: “Worldwide access to vaccines offers the best hope for stopping the coronavirus pandemic, saving lives, and securing a broad-based economic recovery”.
Across the globe, manufacturing companies are keeping a watchful eye on new developments in the spread of COVID. Though US FDA officials don’t think we’ll have to “start at square one” with new vaccines, the March 2021 World Economic Outlook states that “high uncertainty” surrounds the projected 6% global growth. Continued manufacturing success will in large part depend on “the path of the pandemic, the effectiveness of policy support, and the evolution of financial conditions”.
Mathias Cormann, secretary-general of the Organisation for Economic Co-Operation and Development (OECD) concurred—without global immunisation, the estimated economic boom expected by 2025 could go kaput. “We need to...pursue an all-out effort to reach the entire world population”, Australia’s finance minister added. US$50bn to end COVID across the world, they imply, is a small investment to restart our economies.